Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Directorate Change

21 May 2007 07:02

Phorm Inc21 May 2007 Embargoed for release until 7a.m. 21/05/07 Directorate Change Phorm, Inc ("Phorm" or the "Company") Further to the Company's previous announcement on 8th March 2007, the Company(AIM: PHRM and PHRX) is pleased to announce today that David Dorman, ChristopherLawrence and Virasb Vahidi have joined the Board of Phorm, Inc. David Dorman has been an advisor to the Company since July 2006. He is currentlysenior advisor and partner at global private equity firm Warburg Pincus and waspreviously chairman and chief executive officer of AT&T Corp. Before that, hewas CEO of Concert, the global venture created by AT&T and BritishTelecommunications. Mr Dorman serves on the Boards of Motorola, Inc., CVSCorporation, Firethorn Mobile, LLC, and YUM! Brands, Inc. Christopher Lawrence is currently vice chairman of Rothschild, Inc. Prior tojoining Rothschild in 2005, Mr Lawrence was chief strategic officer of CreditSuisse Group as well as a vice chairman of Credit Suisse First Boston. He beganhis investment banking career at Salomon Brothers in 1981. Virasb Vahidi, who is Phorm's chief operating officer, is an internationalbusiness executive with a distinguished career encompassing senior finance,strategy and planning roles in global companies including AT&T Corp. andAmerican Airlines, Inc. Mr Vahidi was most recently senior vice president ofcorporate strategy and development at AT&T, where he was the financial architectof the AT&T Corp/SBC Communications, Inc. merger and co-leader of theintegration team. As also notified on 8th March, David Svendsen, chairman, and Dave Gwozdz havestepped down from the Board of the Company. Dave Gwozdz will remain as US seniorvice president, Business Development and Sales for Phorm. Commenting on the new Board directors, Kent Ertugrul, chairman and CEO of Phorm,said: "We are delighted to welcome Dave, Chris and Virasb to the Board. Theyeach bring complementary skills and experience of an exceptional calibre. Theirwealth of expertise and knowledge will be invaluable as we continue to developour business." "We are grateful to David Svendsen and Dave Gwozdz for their contribution to theBoard and wish them well in the future." Save as set out in the Appendix, there are no further details in relation to theabove appointments which require disclosure under paragraph (g) of Schedule 2 tothe AIM Rules. Ends For EnquiriesPhorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Edelman Financial PR +44 20 7344 1325Paul Lockstone +44 7876 685200 Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb Notes to editors Phorm, Inc. was formerly known as 121Media Inc. Appendix Information provided in accordance with paragraph g of Schedule 2 to the AIMrules: (i) the director's full name and age together with any previous names; David Wyatt Dorman, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of DirectorshipAT&T 2002-2006CVS 2006-PresentFirethorn Mobile, LLC 2006-PresentMotorola 2006-PresentSABRE 1999-2002SAIC 1998-2002Scientific Atlanta 1998-2006Yum! Brands 2005-Present (i) the director's full name and age together with any previous names; Christopher Rueckert Lawrence, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of Directorship:120 East End Avenue 1997 (approximately)-Present (i) the director's full name and age together with any previous names; Virasb Vahidi, Age 40, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; None This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.